Yuta Fujimori

发表

An Sp1 binding site mutation of the PROS1 promoter in a patient with protein S deficiency

T. Naoe, T. Murate, T. Matsushita, 2007, British journal of haematology.

Down-regulation of PROS1 Gene Expression by 17β-Estradiol via Estrogen Receptor α (ERα)-Sp1 Interaction Recruiting Receptor-interacting Protein 140 and the Corepressor-HDAC3 Complex*

T. Murate, H. Saito, A. Takagi, 2010, The Journal of Biological Chemistry.

Molecular defects associated with antithrombin deficiency and dilated cardiomyopathy in a Japanese patient.

K. Node, K. Nagata, T. Murate, 2008, Internal medicine.

Accuracy and stability of saliva as a sample for reverse transcription PCR detection of SARS-CoV-2

Y. Kawaoka, K. Fukunaga, M. Ishii, 2020, Journal of Clinical Pathology.

Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis

M. Murata, M. Wakui, N. Shimizu, 2018, Journal of Clinical Pathology.

Evaluation of anticoagulant effects of direct thrombin inhibitors, dabigatran and argatroban, based on the Lineweaver–Burk plot applied to the Clauss assay

M. Murata, M. Wakui, N. Shimizu, 2016, Journal of Clinical Pathology.

Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations

T. Naoe, T. Murate, Koji Yamamoto, 2009, International journal of hematology.

Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays

M. Murata, M. Wakui, H. Katagiri, 2019, Journal of Clinical Pathology.

A novel ENG mutation causing impaired co-translational processing of endoglin associated with hereditary hemorrhagic telangiectasia.

T. Murate, H. Saito, T. Matsushita, 2012, Thrombosis research.

Reproductive plasticity in response to food source in the fungal-feeding nematode Bursaphelenchus okinawaensis

Yuta Fujimori, R. Shinya, T. Ekino, 2022, Nematology.

Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors

M. Murata, M. Wakui, H. Katagiri, 2020, Journal of Clinical Pathology.

A novel missense mutation causing abnormal LMAN1 in a Japanese patient with combined deficiency of factor V and factor VIII

T. Murate, H. Saito, T. Matsushita, 2009, American journal of hematology.

Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.

T. Naoe, T. Murate, T. Matsushita, 2010, Thrombosis research.

Clot waveform analysis for perioperative hemostatic monitoring in a hemophilia A patient on emicizumab undergoing liver transplantation.

H. Obara, Y. Yatabe, Y. Hasegawa, 2023, Clinica chimica acta; international journal of clinical chemistry.

Evaluation of anticoagulant effects of direct thrombin inhibitors, dabigatran and argatroban, based on the Lineweaver–Burk plot applied to the Clauss assay

M. Murata, M. Wakui, N. Shimizu, 2016, Journal of Clinical Pathology.

Application of clot‐fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis

M. Murata, M. Wakui, H. Katagiri, 2020, International journal of laboratory hematology.